Abstract
Fifty-five children with cholestatic cirrhosis due to extrahepatic biliary atresia received a course of hepatitis B vaccine. Forty-seven received a plasma-derived vaccine and eight a recombinant vaccine. Antibody determination was evaluated before and after liver transplantation in 30 patients. Twenty-five additional patients had antibody determination after transplantation only. Protection against hepatitis B was observed in 73.3% of the children evaluated prior to transplantation. One to 15 months after transplantation, 54.6% of all children studied showed protective levels of anti HBs. We conclude that hepatitis B vaccination is efficient in inducing immunity in the majority of children with cholestatic cirrhosis. Some patients will loose immunity under immunosuppression, but the protection rate remains higher than reported for patients vaccinated after transplantation.
Similar content being viewed by others
References
Maupas P, Chiron JP, Barin F, et al: Efficacy of hepatitis B vaccine in prevention of early HBV carrier state in children. Lancet 1:289–292, 1981
Palmer Beasley R, Hwang LY, Chin-Yun Lee G, et al: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2:1099–1102, 1983
Lee SK, Lee H, Moon SJ, et al: Hepatitis B vaccination of newborn infants: clinical study of new vaccine formulation and dose regimen. Hepatology 7:941–945, 1987
Descos B: La vaccination contre le virus de l'hépatite B. Pediatrie 45:173–179, 1990
Anonymous. Public health: Immunization against hepatitis B. Lancet 1:875–876, 1988
Breinig MK, Zitelli B, Starzl TE, Monto H: Epstein-Barr virus, cytomegalovirus and other viral infections in children after liver transplantation. J Infect Dis 156:273–279, 1987
Cames B, Rahier J, Burtomboy G, Otte JB, Sokal EM: Acute adenovirus hepatitis in liver transplant recipients. J Pediatr 1991 (in press)
Sokal EM, Veyckemans F, de Ville de Goyet J, et al: Liver transplantation in children less than 1 year of age. J Pediatr 117:205–210, 1990
Donati D, Gastaldi L: Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination. Nephron 50:1133–136, 1988
Walz G, Kunzendorf U, Waller H, et al: Factors influencing the response to hepatitis B vaccination of hemodialysis patients. Nephron 51:474–477, 1989
Mendenhall C, Roselle GA, Lybecker LA, et al: Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig Dis Sci 33:263–269, 1988
Collier A, Corey L, Murphy V, et al: Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 109:101–105, 1988
Manucci P, Zanetti A, Gringi A, et al: Long term immunogenicity of a plasma-derived hepatitis B vaccine in HIV-seropositive and HIV-seronegativ ehemophiliacs. Arch Intern Med 149:1222–1237, 1989
Carey W, Pimentel R, Westveer MK, et al: Failure of hepatitis B immunization in liver transplant recipients: Results of a prospective trial. Am J Gastroenterol 85:1590–1592, 1990
Hoofnagle JH: Toward universal vaccination against hepatitis B virus. N Engl J Med 321:1333–1334, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sokal, E.M., Ulla, L. & Otte, J.B. Hepatitis B vaccine response before and after transplantation in 55 extrahepatic biliary atresia children. Digest Dis Sci 37, 1250–1252 (1992). https://doi.org/10.1007/BF01296568
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296568